临床相关性:Prognostic Assessment

A total of 18 records found

#21538 high Confidence
Subject: HPD (protein)
positively_correlates_with
Object: clinical_stage (Clinical staging)
Original: HPD expression level#is positively correlated with#histological grade and clinical stage in breast cancer
🏥 Prognostic Assessment 🧬 HPD 📄 PMID: 31277952
#21537 high Confidence
Subject: HPD (protein)
positively_correlates_with
Object: histological_grade (Pathological grading)
Original: HPD expression level#is positively correlated with#histological grade and clinical stage in breast cancer
🏥 Prognostic Assessment 🧬 HPD 📄 PMID: 31277952
#21380 high Confidence
Subject: AgNOR_expression (Silver-stained nucleolar region expression)
has
Object: prognostic_role (Prognostic role)
Original: AgNOR expression#has#a significant prognostic role
🏥 Prognostic Assessment 📄 PMID: 8996003
#19703 middle Confidence
Subject: AgNOR_quantification (Quantification of silver-stained nucleolar area)
is_necessary_to_assess
Object: prognosis_of_tumors (Tumor prognosis)
Original: AgNOR quantification#is necessary to assess#diagnosis and prognosis of tumors
🏥 Prognostic Assessment 📄 PMID: 8180776
#19684 middle Confidence
Subject: histopathological_typing (Diagnostic Methods)
has
Object: prognostic_value (Prognostic indicators)
Original: Histopathological typing of breast carcinomas#has#relatively good prognostic value
🏥 Prognostic Assessment 📄 PMID: 9042313
#19080 middle Confidence
Subject: nucleoli_cytomorphology (Cellular substructure)
offers
Object: prognostic_approach (Prognostic indicators)
Original: Nucleoli cytomorphology in melanoma cells#offers#a new prognostic approach
🏥 Prognostic Assessment 📄 PMID: 29284501
#18945 middle Confidence
Subject: biological_malignancy_pancreatic_carcinoma (Tumor Biology)
is_evaluated_by
Object: AgNOR_score (Histological markers)
Original: Biological malignancy of pancreatic carcinoma#is evaluated by#Ag-NOR score in resected specimens
🏥 Prognostic Assessment 📄 PMID: 9130343
#18944 middle Confidence
Subject: ras_p21 (Small G protein)
is_lower_in
Object: non_progressing_cases (Tumor cells)
Original: expression of ras p21#is greater in#progressing stage A cancer cells compared to non-progressing cases
🏥 Prognostic Assessment 🧬 RAS 📄 PMID: 7542162
#18943 middle Confidence
Subject: ras_p21 (Small G protein)
is_higher_in
Object: progressing_stage_A_cancer_cells (Tumor cells)
Original: expression of ras p21#is greater in#progressing stage A cancer cells compared to non-progressing cases
🏥 Prognostic Assessment 🧬 RAS 📄 PMID: 7542162
#15847 middle Confidence
Subject: growth_potential_of_pituitary_adenomas (Tumor Biology)
was_analyzed_using
Object: AgNOR_count (Nucleolar Organizer Region Protein)
Original: Growth potential of pituitary adenomas#was analyzed using#Ki-67/ anti-DNA polymerase alpha/ BrdUdR labeling/ and AgNOR counts
🏥 Prognostic Assessment 🧬 KI67 📄 PMID: 1381860
#15846 middle Confidence
Subject: growth_potential_of_pituitary_adenomas (Tumor Biology)
was_analyzed_using
Object: BrdUdR_labeling (Cell proliferation markers)
Original: Growth potential of pituitary adenomas#was analyzed using#Ki-67/ anti-DNA polymerase alpha/ BrdUdR labeling/ and AgNOR counts
🏥 Prognostic Assessment 🧬 KI67 📄 PMID: 1381860
#15845 middle Confidence
Subject: growth_potential_of_pituitary_adenomas (Tumor Biology)
was_analyzed_using
Object: DNA_polymerase_alpha (DNA Synthesizer)
Original: Growth potential of pituitary adenomas#was analyzed using#Ki-67/ anti-DNA polymerase alpha/ BrdUdR labeling/ and AgNOR counts
🏥 Prognostic Assessment 🧬 KI67 📄 PMID: 1381860
#15844 middle Confidence
Subject: growth_potential_of_pituitary_adenomas (Tumor Biology)
was_analyzed_using
Object: KI67 (Cell proliferation markers)
Original: Growth potential of pituitary adenomas#was analyzed using#Ki-67/ anti-DNA polymerase alpha/ BrdUdR labeling/ and AgNOR counts
🏥 Prognostic Assessment 🧬 KI67 📄 PMID: 1381860
#15676 middle Confidence
Subject: differentiation_of_prostatic_carcinoma (Diagnostic Methods)
is_important_for
Object: prognosis (Prognostic indicators)
Original: Differentiating prostatic carcinoma#is important for#prognosis and therapy
🏥 Prognostic Assessment 📄 PMID: 7511310
#11539 middle Confidence
Subject: AgNOR_staining (Dyeing technology)
is_evaluated_as
Object: prognostic_indicator (Prognostic indicators)
Original: Histologic grading and AgNOR staining#are evaluated as#prognostic indicators
🏥 Prognostic Assessment 🧬 PCNA 📄 PMID: 7863578
#11538 middle Confidence
Subject: histologic_grading (Histological grading)
is_evaluated_as
Object: prognostic_indicator (Prognostic indicators)
Original: Histologic grading and AgNOR staining#are evaluated as#prognostic indicators
🏥 Prognostic Assessment 🧬 PCNA 📄 PMID: 7863578
#6473 middle Confidence
Subject: AgNOR_parameter (Nucleolus related parameters)
is_a_tool_for
Object: clinical_outcome_definition (Clinical Outcomes)
Original: AgNOR parameter#is a tool for#defining clinical outcome of cancer disease
🏥 Prognostic Assessment 📄 PMID: 10588056
#2918 low Confidence
Subject: Ag-NOR_number (Nucleolar organizer region-associated protein)
may_restrict
Object: prognostic_value_in_individual_cases (Prognostic assessment ability)
Original: Overlapping of Ag-NOR numbers among malignancy groups#may restrict#prognostic value in individual cases
🏥 Prognostic Assessment 📄 PMID: 1527622